Solesence, Inc. (SLSN)

NASDAQ: SLSN · Real-Time Price · USD
1.190
-0.060 (-4.80%)
May 19, 2026, 10:57 AM EDT - Market open
Market Cap84.05M -60.9%
Revenue (ttm)60.40M +5.8%
Net Income944,000 -72.4%
EPS0.01 -81.7%
Shares Out 70.63M
PE Ratio135.43
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,343
Open1.230
Previous Close1.250
Day's Range1.187 - 1.230
52-Week Range0.780 - 5.630
Beta1.30
Analystsn/a
Price Target1.50 (+26.05%)
Earnings DateMay 12, 2026

About SLSN

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnost... [Read more]

Founded 1989
Employees 115
Stock Exchange NASDAQ
Ticker Symbol SLSN
Full Company Profile

Financial Performance

In 2025, Solesence's revenue was $62.06 million, an increase of 18.56% compared to the previous year's $52.35 million. Earnings were $1.79 million, a decrease of -57.73%.

Financial Statements

News

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, bu...

4 days ago - GlobeNewsWire

Solesence Earnings Call Transcript: Q1 2026

Revenue declined year-over-year due to shipment delays, but gross margin improved and a healthy $47M order pipeline supports a positive outlook. Strategic investments and new technology launches position the company for margin expansion and long-term growth.

7 days ago - Transcripts

Solesence Earnings release: Q1 2026

Solesence released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.

7 days ago - Filings

Solesence Quarterly report: Q1 2026

Solesence has published its Q1 2026 quarterly earnings report on May 12, 2026.

7 days ago - Filings

Solesence Slides: Q1 2026

Solesence has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 12, 2026.

7 days ago - Filings

Solésence Reports First Quarter 2026 Financial Results

Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence,...

7 days ago - GlobeNewsWire

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment

8 days ago - GlobeNewsWire

Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12

ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...

20 days ago - GlobeNewsWire

Solésence, Inc. Announces Appointment of New Independent Director

Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees ROMEOVILLE, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scien...

22 days ago - GlobeNewsWire

Solesence Earnings Call Transcript: Q4 2025

Revenue hit a record $62.1M in 2025, up 18.6% year-over-year, but margin compression limited profit growth. Operational improvements and the Transform and Transcend initiative aim to boost margins and EBITDA in 2026, with a 30% gross margin floor set.

7 weeks ago - Transcripts

Solesence Annual report: Q4 2025

Solesence has published its Q4 2025 annual report on March 31, 2026.

7 weeks ago - Filings

Solesence Earnings release: Q4 2025

Solesence released its Q4 2025 earnings on March 31, 2026, summarizing the period's financial results.

7 weeks ago - Filings

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beaut...

7 weeks ago - GlobeNewsWire

Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...

2 months ago - GlobeNewsWire

Solesence appoints Yoolie Park as VP, brand partnerships

Solesence has appointed Yoolie Park as Vice President of Brand Partnerships. In this role, Park will lead strategic relationships with emerging and established beauty brands, expanding Solesence’s abi...

2 months ago - TheFly

Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships

Park brings over 20 years of industry experience to expand innovation and drive brand partner growth ROMEOVILLE, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scie...

2 months ago - GlobeNewsWire

Solesence Earnings Call Transcript: Q3 2025

Q3 2025 saw a 14% revenue decline and a net loss, impacted by industry softness and operational inefficiencies, but full-year sales are up $10–12 million. Leadership changes, cost controls, and facility consolidation are expected to restore margins and drive future growth, with guidance for improved profitability and continued outperformance in mineral-based beauty.

6 months ago - Transcripts

Solesence Quarterly report: Q3 2025

Solesence has published its Q3 2025 quarterly earnings report on November 11, 2025.

6 months ago - Filings

Solesence Earnings release: Q3 2025

Solesence released its Q3 2025 earnings on November 11, 2025, summarizing the period's financial results.

6 months ago - Filings

Solesence reports Q3 EPS (2c) vs 4c last year

Reports Q3 revenue $14.5M vs $16.9M last year. “As part of our ongoing transformation, Solesence implemented several strategic initiatives driving improvements in innovation, product quality and opera...

6 months ago - TheFly

Solésence Reports Third Quarter 2025 Financial Results

Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a lea...

6 months ago - GlobeNewsWire

Solesence appoints Yoana Dvorzsak as VP, innovation, product integrity

Solesence appointed Yoana Dvorzsak to the newly created role of Vice President of Innovation and Product Integrity to support the Company’s continued innovation and operational excellence in its new p...

6 months ago - TheFly

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLO...

6 months ago - GlobeNewsWire

Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call

ROMEOVILLE, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...

7 months ago - GlobeNewsWire

Solesence appoints Kevin Cureton as president, CEO

Solesence announced strategic changes to its executive leadership. Kevin Cureton will assume the role of President and CEO. Laura Riffner has been appointed CFO. Jess Jankowski, who has been at…

9 months ago - TheFly